Don't believe the appealing will change much, the Eli contract termination has totally destroyed the company's sole asset Axiron.
Only if they can announce a new alternative or a breakthrough on the pipeline front, with all of those in early stage I doubt any meaningful news around this time.
Is any small Biotech in Aus ever* going to make it?, page-36
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 110000 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1974 | 1 |
View Market Depth
| Last trade - 07.00am 01/11/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable